Clinical trial NCT01774448: Mindfulness Research Program: Designed to Enhance Wellbeing in People Living With Dementia and Their Spouses
Official title: The Efficacy of Mindfulness-Based Cognitive Therapy (MBCT) to Improve Depression Symptoms and Quality of Life in Individuals With Dementia and Their Caregivers: A Pilot Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Dementia
Keywords: Dementia
Spouse Caregiver
Depression
Mind Body Therapy
Cognitive Therapy
Quality of Life
Attention
Memory
Lead sponsor: Lakehead University
Sponsor class: OTHER
Collaborators: name: Alzheimer Society of Canada
First posted: 2013-01-24
Enrollment: 36
Sex: ALL
Minimum age (years): 50
Maximum age (years): 85
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: SUPPORTIVE_CARE

Brief summary: People with dementia forget things and have trouble concentrating. In addition, they and their caregivers can become depressed. This project will show whether Mindfulness-Based Cognitive Therapy (MBCT) can lessen depression, increase attention spans and improve quality of life for those affected by the disease and their caregivers.

MBCT combines intensive training in mindfulness meditation with Cognitive Behavioural Therapy. Studies show the meditation component creates changes in areas of the brain associated with our ability to pay attention. This form of meditation can help those impacted by dementia become more aware of their depressive thinking, leading to improved ways of coping.

The investigators predict that individuals in the early stages of dementia and their spousal caregivers will report fewer depression symptoms following the 8-week Mindfulness-Based Cognitive Therapy (MBCT) Program, as well as experience improvements in quality of life and daily mindfulness.

If successful, MBCT could improve the quality of life in individuals with dementia and their caregivers, as well as may take pressure off the health care system by delaying institutionalization.

Detailed description: The overall objective of the proposed study is to investigate the efficacy of Mindfulness-Based Cognitive Therapy (MBCT) to alleviate depression symptoms, increase attention abilities, and improve quality of life in individuals with dementia and their caregivers. MBCT works to help individuals increase concentration and increase awareness of depressive thinking to ultimately provide a better means of coping and emotional regulation.

While dementia is non-reversible and progressive in nature, supportive interventions, especially at the early stage of the disease, can make life more manageable for both dementia individuals and their caregivers. Along with the initial signs of forgetfulness and concentration difficulties, it is common for both individuals with dementia and their primary caregivers to also experience depression symptoms. For dementia individuals, depression symptoms are common early on as they still have insight into their disease. This increase in depression has been shown to be related to apathy, overall poorer quality of life and cognitive decline. Caregivers not only witness a significant change in daily functioning of someone they love and know well, they are also faced with new responsibilities associated with managing the disease, while simultaneously trying to juggling their own day-to-day tasks. These drastic changes and increased responsibilities have been shown to increase feelings of depression and burden, resulting in coping-related problems in caregivers.

Counseling intervention in early stages of dementia has been shown to delay and even decrease patient admittance into long-term facilities, ultimately relieving stress placed on the healthcare system. MBCT is a specific program designed to, and proven successful at, treating various populations with recurrent depression. With its unique therapeutic approach of integrating intensive training in mindfulness meditation with Cognitive Behavioural Therapy, MBCT helps individuals pay greater attention, increase concentration, increase awareness of depressive thinking and learn to apply more skillful means of coping. In addition to treating depression, the meditation component of MBCT has also been shown to improve various aspects of attention and result in changes in neural networks implicated in attention processes. The investigators predict that MBCT will alleviate depression symptoms and increase quality of life in both patients and caregivers. The investigators also expect that individuals will experience improvements in attention and memory abilities.

If successful, MBCT could improve overall quality of life in dementia individuals and caregivers, as well as benefit our healthcare system by delaying institutionalization. From a research perspective, success of this program may lead to a larger clinical controlled trial to further investigate the efficacy of MBCT in individuals affected by dementia.

Eligibility criteria: Inclusion Criteria:

* Early stages of dementia
* Spousal caregiver (no signs of dementia/mild cognitive impairment)
* Evidence of at least mild depression (in at least one partner)
* Speak, read, and write in English

Exclusion Criteria:

* Neurological Disorder (other than dementia for dementia group)
* Psychological Disorder

Primary outcomes:
measure: Change in Depression Symptoms
timeFrame: 10 weeks
Secondary outcomes:
measure: Change in Apathy Levels
timeFrame: 10 weeks
measure: Change in Quality of Life
timeFrame: 10 weeks
measure: Change in Anxiety Levels
timeFrame: 10 weeks
measure: Change in Levels of Coping
timeFrame: 10 Weeks
measure: Change in Burden Levels
timeFrame: 10 Weeks
measure: Change in Levels of Self-Compassion
timeFrame: 10 weeks
measure: Change in Cognitive Functioning
timeFrame: 10 Weeks
measure: Change in Cognitive Functioning
timeFrame: 10 weeks
measure: Change in Working Memory
timeFrame: 10 Weeks
measure: Change in Cognitive Flexibility
timeFrame: 10 weeks
measure: Change in Verbal Fluency
timeFrame: 10 weeks
measure: Change in Short-Term Verbal Memory
timeFrame: 10 weeks
measure: Change in Attention
timeFrame: 10 weeks
measure: Change in Depression Symptoms
timeFrame: 10 weeks
measure: Change in Levels of Mindfulness
timeFrame: 10 weeks
Other outcomes:
Locations:
Study officials:
affiliation: Lakehead University
name: Lana J Ozen, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Lakehead University
name: Michel Bedard, PhD
role: STUDY_DIRECTOR
References: